HALOZYME THERAPEUTICS, INC.
Public company- Headquarters
- SAN DIEGO, California
- Industry
- Biotechnology
- Ticker
- HALO
- CIK
- 0001159036
WARN notices since 2024
Workers affected since 2024
Executive changes, last 12 months
Last event
Workers affected over time
Cumulative workers in WARN notices since 2024
Not enough notices to chart yet.
Leadership
| Role and person | Since | Change |
|---|---|---|
| directorJames Daly | Sep 30, 2026 | Appointed |
Related companies
Same industry and state, with recent events.
- Vir Biotechnology, Inc.
Class III director appointed: Suzanne Topalian, M.D.
- AMGEN INC
director appointed: David W. Gibbs
- Cardiff Oncology, Inc.
CMO appointed: Leila Alland
- Vaxart, Inc.
member of the Board appointed: Raquel C. Bono, M.D., M.B.A., FACS
- Executive appointment
director appointed: James Daly
James Daly was named director of HALOZYME THERAPEUTICS, INC., effective September 28, 2026. The company reported the change in an 8-K that cites Item 5.02.
Source: SEC 8-K, filed Sep 30, 2026Role: director
- Executive appointment
director appointed: Dannielle Appelhans
Dannielle Appelhans was named director of HALOZYME THERAPEUTICS, INC., effective August 14, 2026. The company reported the change in an 8-K that cites Item 5.02.
Source: SEC 8-K, filed Aug 18, 2026Role: director
Last verified Nov 8, 2026